Compare EICC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EICC | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 104.6M |
| IPO Year | N/A | N/A |
| Metric | EICC | ORMP |
|---|---|---|
| Price | $25.32 | $2.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.7K | ★ 243.2K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 7.96% | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | 0.55 | ★ 1.03 |
| Revenue | ★ $51,224,692.00 | $2,000,000.00 |
| Revenue This Year | $39.61 | N/A |
| Revenue Next Year | $27.28 | N/A |
| P/E Ratio | $23.44 | ★ $2.65 |
| Revenue Growth | ★ 68.61 | N/A |
| 52 Week Low | $23.75 | $1.82 |
| 52 Week High | $25.25 | $3.09 |
| Indicator | EICC | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 56.24 | 61.11 |
| Support Level | $25.25 | $2.68 |
| Resistance Level | $25.34 | $2.84 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 66.63 | 63.51 |
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.